| abstract |
Disclosed herein is a combination product or medicament comprising at leaset one-substituted pyrrole derivative of the given formula, with one or more dyslipidemic agents selected from the group of etofibrate, fenofibrate, clofibrate, gemfibrozil, bezafibrate, ciprofibrate, clinofibrate or theofibrate. Said combination product is used in the treatment of cardiovascular diseases, Alzheimer's disease, obesity, diabetes or inflammatory diseases. |